Expression-based drug screening of neural progenitor cells from individuals with schizophrenia
Unbiased large scale screening of small molecules for drug discovery in psychiatric disease is technically challenging and financially costly. Here, Readhead and colleagues integrate in silico and in vitro approaches to design and conduct transcriptomic drug screening in schizophrenia patient-derive...
Guardado en:
Autores principales: | Benjamin Readhead, Brigham J. Hartley, Brian J. Eastwood, David A. Collier, David Evans, Richard Farias, Ching He, Gabriel Hoffman, Pamela Sklar, Joel T. Dudley, Eric E. Schadt, Radoslav Savić, Kristen J. Brennand |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ed2d9e5658de4fa6b0313e02ddefca0f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: Expression-based drug screening of neural progenitor cells from individuals with schizophrenia
por: Benjamin Readhead, et al.
Publicado: (2018) -
Transcriptional signatures of schizophrenia in hiPSC-derived NPCs and neurons are concordant with post-mortem adult brains
por: Gabriel E. Hoffman, et al.
Publicado: (2017) -
What if it was easier to prevent schizophrenia than to treat it?
por: Kristen J. Brennand
Publicado: (2017) -
Integrative transcriptome imputation reveals tissue-specific and shared biological mechanisms mediating susceptibility to complex traits
por: Wen Zhang, et al.
Publicado: (2019) -
Evaluation of chromatin accessibility in prefrontal cortex of individuals with schizophrenia
por: Julien Bryois, et al.
Publicado: (2018)